trending Market Intelligence /marketintelligence/en/news-insights/trending/jInd2dMCQ-UdSa-lGPVi0g2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

DuPont lifts 2019 pro forma adjusted EPS outlook as adjusted EPS beats estimates

Medical IoT Technology in US Hospitals Helps to Reduce Costs and Improve Care

Internet Traffic Spikes By One Third In March

How 37 Years of Default Data Can Prepare Us for the COVID-19 Fallout

US Pushes Pedal To The Metal On Broadband Speeds Ahead Of COVID-19 Outbreak


DuPont lifts 2019 pro forma adjusted EPS outlook as adjusted EPS beats estimates

DuPont de Nemours Inc. lifted its 2019 pro forma adjusted EPS guidance after the second-quarter adjusted EPS surpassed analyst expectations.

The company booked a net loss attributable to DuPont common stockholders of $571 million, or 76 cents per share, in the second quarter ended June 30, compared with attributable net income of $1.77 billion, or $2.27 per share, in the year-earlier period.

Adjusted net income rose 4% year over year to $725 million, or 97 cents per share, from $695 million, or 89 cents per share reported in the year-ago period. The S&P Global Market Intelligence consensus normalized EPS estimate for the second quarter was 82 cents.

Net sales fell 7% year over year to $5.47 billion from $5.86 billion amid lower autobuilds and weaker electronics demand in the transportation and industrial division as well as currency headwinds across all divisions.

Meanwhile, cost of sales fell 14% to $3.50 billion from $4.09 billion.

DuPont said it raised its full-year 2019 pro forma adjusted EPS to $3.75 to $3.85 but slightly lowered its organic growth outlook compared with the prior year.

The company's net loss from continuing operations came in at $1.10 billion, or $1.48 per share, primarily affected by a pretax goodwill impairment charge of $1.18 billion.

In May, the company said it expected to book a pretax goodwill impairment charge of $800 million to $1.3 billion in the second quarter. This reflected unfavorable market conditions, including a demand slowdown in the biomaterials business and challenging conditions in U.S. bioethanol markets. The impairment charge followed after DowDuPont completed the spinoff of its material sciences division on April 1 as part of its breakup process.

Through June 30, the company's net loss attributable to DuPont common stockholders totaled $50 million, or 7 cents per share, down from attributable net income of $2.86 billion, or $3.69 per share, recorded in the prior-year period.